ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Valeritas Holdings Inc

Valeritas Holdings Inc (VLRX)

0.2568
0.00
(0.00%)
Closed December 29 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.2568
Bid
0.25
Ask
0.2549
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.2568
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

VLRX Latest News

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees Company and Subsidiaries Commence Voluntary Chapter 11 to Facilitate Value-Maximizing Sale Commercially...

Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...

BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...

BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

BRIDGEWATER, N.J., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced...

Valeritas Announces Third Quarter 2019 Financial Results

BRIDGEWATER, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

BRIDGEWATER, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

BRIDGEWATER, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...

BRIDGEWATER, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...

BRIDGEWATER, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...

BRIDGEWATER, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

VLRX - Frequently Asked Questions (FAQ)

What is the current Valeritas share price?
The current share price of Valeritas is US$ 0.2568
What is the 1 year trading range for Valeritas share price?
Valeritas has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
187.57M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
557.72M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.65M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.75M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
129.92M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

Discussion

View Full Feed
SkeBallLarry SkeBallLarry 12 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 13 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Phoenix2020 Phoenix2020 14 minutes ago
Friday's daily short sale volume was 74.61% (as reported by FINRA) and it seems that the shorts are trying hard to manipulate the market! The short borrow fee is 12.87% and the shorts have increased their position by another 600'000 shares to 6.14 million shares that are currently shorted. It should
CVM
SkeBallLarry SkeBallLarry 14 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 15 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
cowtown jay cowtown jay 15 minutes ago
Here's a partial transcript of a discussion between Dr. John Campbell and Dr. Angus Dalgleish regarding a drug similar to lenz.

"21:17
we've done the phase one phase two is does it work every single phase two study we've done it clearly is of
21:23
benefit phase t
SkeBallLarry SkeBallLarry 17 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Nrdc92 Nrdc92 32 minutes ago
Written like someone who doesn't have a clue, Jeunke. Beyond the rampant speculation in your post, it is ludicrous to believe that LWLG is in Tier 1 negotiations. No company during critical, major negotiations jettisons a respected  scientist and the company's CEO without a meaningful public explana
LWLG
Alexulf Alexulf 42 minutes ago
Steve Reinharz: A Visionary Leader in AI and Security Innovation


Steve Reinharz, the CEO and CTO of Artificial Intelligence Technology Solutions (AITX), is a true visionary in the field of AI and security innovation. His passion for developing AI-powered, autonomous security s
AITX
Iggy_Bot Iggy_Bot 50 minutes ago
If i can answer for Kash, the answer would be Nothing as usual. feckless
FireMechanic FireMechanic 51 minutes ago
Tne dow isn't 43,000 and Bitcoin isn't 100K!!! The current administration is working with the right people to keep these numbers. Unfortunately they will drop this in trump administration lap and say it's his fault. Gonna be millions of people in the world hurting soon mostly because of our crooked
BTCUSD
theswordman theswordman 54 minutes ago
💯
CKPT
janetcanada janetcanada 55 minutes ago
***I have been reading this in the past???....

1️⃣ 5 cents. Nickel.
2️⃣10 cents. Dime.
3️⃣ 25 cents Quarter.
4️⃣1 dollar.
RDAR
theswordman theswordman 56 minutes ago
The official answer is at clinical trials . gov.

Trial NCT06699836

It is a PH II with est start FEB 2025

est finish JUN 2028

60 patients. Last update 21 NOV 2024

This is an open label, randomized, two arm, multi-center study
MSS
123tom 123tom 60 minutes ago
Looking at the chart, I'm thinking first the 10 to 9 area, in the next wave down. It would look discouraging to see a great rally from 8.50 to 14.50 fall all the way back down... that wouldn't feel like how a good news rally should be. I'd be ok to watch it hold at 10-11 and begin the next surge
AVXL
NocRob NocRob 1 hour ago
Those options are all for Berman at $0.21 with a sweetener around an acquisition. Both that strategy and Berman in general have proven to be complete busts. But if this somehow pushes past $0.21, I’m out and never looking back.
BLPG
wallstreet1231 wallstreet1231 1 hour ago
There has been nothing to cheer about.

Zero sales last two reporting period.

Filings still delinquent - what, over a year now.

A manufacturing facility-where?Me no see.

Oh, and a manufacturing facility - where?

And now chee
SNPW
demonsmith demonsmith 1 hour ago
Should I sale to you at 0.02
HLLK
LEFTY1182 LEFTY1182 1 hour ago
Where did he say that at?
RSPI
Plato_ Plato_ 1 hour ago
You're right MasterBlastr. Some here, with very large positions, have already announced that when the price hits 0.016 they will be "dumping stock on the market."
Between middle of July and end of September, I picked up millions and millions of millions of shares, at some point I recall a tr
GDVM
imbellish imbellish 1 hour ago
“Yeah I’m short from 45 cents still and it’s don’t know how the dollar works please protect me government”
FNMA
Elroy Jetson Elroy Jetson 2 hours ago
Mr T says he has "special talent" H1-B workers employed at his hotel properties, so H1-B visa workers are terrific - it's farm workers, builders and restaurant workers we need to deport, just like the UK did with Brexit.

Looking forward to food shortages and much higher prices at our
Livi1 Livi1 2 hours ago
I have a couple of paid bashers here on ignore.
The only time I see their names is when someone replies to them. $CNNA
CNNA
CrossFireTrader CrossFireTrader 2 hours ago
Well you can never fault a Man for making a profit, yet it seems that you have re-assessed GDVM, and it's potential, and lost faith in Melvin. As selling into short term capital gains is a tuff pill to swallow. Something tells me that by the time you get ready to pull the you may have a change of he
GDVM